2010 Presentations

UBC scientists participate in scientific and clinical meetings around the world. To learn more about a presentation, please contact the UBC scientist directly or call 301-654-9729.

  • 52nd American Society of Hematology Meeting and Exposition

    Dec 4 - Dec 7 2010
    Orlando, FL, USA
    www.hematology.org/Meetings/Annual-Meeting/

    PRESENTATION
    Variation in Health-Related Quality of Life (HRQOL) by ISS Stage and ECOG Status Among Multiple Myeloma Patients
    Pashos CL, Durie BGM, Rifkin R, Shah J, Street T, Sullivan K, Khan ZM

  • Late Phase Drug Development World 2010

    Nov 30 - Dec 3 2010
    London, UK
    www.healthnetworkcommunications.com/2010/lpdd/


    PRE-CONFERENCE WORKSHOP
    Management of Differences (or Variations) within the EU Guidelines for Non-Interventional Studies
    Hazel Wohlfahrt, Exec. Director, EU Clinical Operations, United BioSource Corp., Jess Sohal, Exec. Director, EU Clinical Operations, United BioSource Corp.

    PRESENTATION
    The Right Evidence, Using the Right Decision, and the Right Tools
    Krista Payne, MEd, Director and Research Scientist, Health Care Data Capture, United BioSource Corp.

  • Gerontological Society of America's 63rd Annual Scientific Meeting

    Nov 19 - Nov 23 2010
    New Orleans, LA, USA
    www.geron.org/Annual%20Meeting

    POSTER PRESENTATION
    The Prevalence and HRQL Impact of OAB in Older Adults: Results from EpiLUTS
    Markland A, Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen C-I

  • 7th Forum on Patient Reported Outcomes (PRO)

    Nov 17 - Nov 18 2010
    Philadelphia, PA, USA
    www.cbinet.com/show_conference.cfm?confCode=PC10189

    PRE-CONFERENCE WORKSHOP
    Use Responder Analysis to Support Label Claims for Patient Reported Outcomes
    Joseph C. Cappelleri, PhD, MPH, Sr. Dir., Biostatistics, Pfizer; Kathleen W. Wyrwich, PhD, Sr. Research Scientist, Center for Health Outcomes Research, United BioSource Corp.

  • American Heart Association (AHA) Scientific Sessions 2010

    Nov 13 - Nov 17 2010
    Chicago, IL, USA
    scientificsessions.americanheart.org/portal/scientificsessions/ss/

    POSTER PRESENTATION
    Is There an Association Between Aspirin Dosing and Cardiac and Bleeding Events in Acute Coronary Syndrome After Stent Placement? A Systematic Review of the Literature
    Berger JS, Sallum RH, Katona B, Maya J, Ranganathan G, Mwamburi M

  • The American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting 2010

    Nov 11 - Nov 16 2010
    Phoenix, AZ
    www.acaai.org/


    POSTER PRESENTATION
    An Assessment of Change in Quality of Life Among Patients 12 Years and Older with Persistent Asthma in Mometasone Furoate/Formoterol Fumarate Clinical Trials
    Wyrwich K

    An Assessment of Change in Asthma Control Among Patients 12 Years and Older With Persistent Asthma in Mometasone Furoate/Formoterol Fumarate Clinical Trials
    Wyrwich K

  • ISPOR 13th Annual European Congress

    Nov 6 - Nov 9 2010
    Prague, Czech Republic
    www.ispor.org/

    EDUCATIONAL SYMPOSIUM
    Sat., 6 Nov., 18:15 - 19:15

    Orphan Drugs in Europe: Funding Challenges for Payers and Developers
    Moderator: Adam Barak, MCIM, Head of International Pricing and Reimbursement, United BioSource Corp.
    Speakers: Adam Barak, MCIM, Head of International Pricing and Reimbursement, United BioSource Corp., London, UK; Wills Hughes-Wilson, Senior Director, Health Policy Europe, Genzyme, Brussels, Belgium; Francis Pang, MSc, Phil, Senior Market Access & Public Affairs Director, Shire, Basingstoke, UK; Stefan Lange, PD Dr. Med., Deputy Director, German Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany


    SHORT COURSE
    Sat., 6 Nov., 9:00 - 18:00

    Discrete Event Simulation for Economic Analyses
    Faculty: J. Jaime Caro, MDCM, FCRPC, FACP, Adjunct Prof. of Medicine, Adjunct Prof. of Epidemiology and Biostatistics, McGill University, Montreal PQ, and SVP of Health Economics, United BioSource Corp.; Jorgen Moller, MSc Mech Eng, VP, Modeling, United BioSource Corp.


    WORKSHOPS
    Sun., 7 Nov., 16:00 - 17:00  SESSION I

    W1: Conducting & Interpreting Indirect Treatment Comparison and Network Meta-Analysis: Learning the Basics
    Discussion Leaders: Jeroen P. Jansen, PhD, MSc, Research Director, Mapi Values; Neil Hawkins, PhD, Director, Oxford Outcomes Ltd.; Joseph C. Cappelleri, PhD, MPH, Pfizer Inc.; Rachael Fleurence, PhD, Senior Research Scientist and Director, Practice for Evidence Review and Synthesis, United BioSource Corp.

    W6: Innovative Methods for Electronically Capturing Patient-Reported Outcomes and Preference Data in Non-Interventional Studies
    Discussion Leaders: Ingela Wiklund, PhD, Senior Research Leader, Center for Health Outcomes Research, United BioSource Corp.; Sonya Eremenco, MA, e-PRO Manager, United BioSource Corp.

    Sun., 7 Nov., 17:15 - 18:15  SESSION II

    W8: Understanding Mixed Treatment Comparisons (MTCS): What Do the Results Mean and How Should They be Used?
    Discussion Leaders: Rachael Fleurence, PhD, Senior Reserach Scientist and Director, Practice for Evidence Review and Synthesis, United BioSource Corp.; Huseyin Naci, Research Associate II, United BioSource Corp.; David Vanness, PhD, Assistant Prof., Dept. of Population Health Sciences, Univ. of Wisconsin School of Medicine and Public Health

    Tues., 9 Nov., 14:45 - 15:45  SESSION III 

    W16: Model Validation: Buyer Beware
    Discussion Leaders: Ipek Ozer Stillman, MS, Research Scientist, United BioSource Corp.; Phil McEwan, PhD, Managing Director, Cardiff Research Consortium; Denis Getsios, Research Scientist, United BioSource Corp.

    W18: Time-to-Progression Models: Rapidly Informing Indications in Oncology
    Discussion Leaders: Georgia Mitsi, PhD, MBA, MSc, Manager, United BioSource Corp.; Zeba M. Khan, PhD, RPh, VP, Pricing & Market Access, Celgene Corp.; J. Jaime Caro, MDCM, FRCPC, SVP of Health Economics, United BioSource Corp.


    ISSUE PANELS
    Sun., 7 Nov., 14:45 - 15:45  SESSION I

    IP2:     Methods or Pragmatism: Who Should Have the Say in Health Economic Assessment?
    Moderator: J. Jaime Caro, MD, SVP of Health Economics, United BioSource Corp.
    Panelists: Andreas Gerber, MD, PhD, Head, Dept. of Health Economics, Insititue for Quality and Efficiency in Health Care (IQWiG); Lise Rochaix, PhD, Professor, Commission d'evaluation economique et de sante publique (CEESP); Gert Jan van der Wilt, PhD, Professor, Dept. of Epidemiology, Biostatistics and HTA, Radboud University Medical Centre

    IP4: Rare (Orphan) Disease: Tension Between Government Support of Developing New Therapies and Reimbursement Processes? Perspectives From EU-5 (Germany, UK, France, Spain and Italy), Central & Eastern Europe, USA and Canada
    Moderator: Vladimir Zah, PhD, Health Economics Consultant, Belgrade, Serbia
    Panelists: Chris Pashos, PhD, VP, United BioSource Corp.; Mondher Toumi, PhD, MD, Prof. of Decision Sciences, UFR d'Odontologie, Univ. Claude Bernard Lyon 1; Zoltan Kalo, MD, MSc, PhD, Director, Health Economics Research Unit, Eotvos Lorand Univ.

    IP5: Is Any Data Better Than No Data? The Use of Mixed Modalities for PRO Data Collection in Clinical Trials
    Moderator: Sonya Eremenco, MA, e-PRO Manager, United BioSource Corp.
    Panelists: Stephen Joel Coons, PhD, Director, Patient-Reported Outcomes (PRO) Consortium, Critical Path Institute; Ethan Basch, MD, MSc, Principal Investigator, Health Outcomes Group, Memorial Sloan-Kettering Cancer Center; Tara Symonds, PhD, Sr. Dir., PRO Centre of Excellence, Global Market Access, PCBU, Pfizer

    Mon., 8 Nov., 10:15 - 11:15 SESSION II

    IP9: Greece's National Drug Budget Cut: What Will Be Its Impact on Europe?
    Moderator: Chris Pashos, PhD, VP, United BioSource Corp.
    Panelists: John Yfantopoulos, PhD, Prof., Faculty of Political Science and Public Administration, National and Kapodistrian Univ. of Athens; Mary Geitona, PhD, Asst. Prof., Dept. of Economics, Univ. of Thessaly; Adam Barak, Head, International Pricing & Reimbursement

    Mon., 8 Nov., 14:00 - 15:00 SESSION III

    IP13: EBM, HTA, CER: Clearing the Confusion Or Are We Now Confused at a Higher Level?
    Moderator: Bryan R. Luce, PhD, MBA, SVP, Science Policy, United BioSource Corp.
    Panelists: Marc L. Berger, MD, VP, Global Health Outcomes, Eli Lilly and Co.; Penny Mohr, MA, VP, Center for Medical Technology Policy; Finn Borlum Kristensen, MD, PhD, Dir. and Coordinating Secretariat, European Network for Health Technology Assessment (EUnetHTA) and Chairman of the EUnetHTA Executive Committee

    IP14: QALY or the Need for a New Approach?
    Moderator: Peter Kolominsky-Rabas, MD, PhD, MBA, Director, Centre for Health Technology Assessment (HTA) and Public Health (IZPH), University of Erlangen-Nurnberg
    Panelists: J. Jaime Caro, MD, SVP of Health Economics, United BioSource Corp.; Mark J. Sculpher, PhD, Prof. of Health Economics, Centre for Health Economics, The University of York

    Tues., 9 Nov., 10:00 - 11:00 SESSION IV

    IP18: What Opportunities are Emerging Today to Harmonise Efforts to Generate Evidence Needed by Regulators, Payers and Drug Developers?
    Moderator: Lisbet Coulton, Director, International Pricing and Reimbursement, United BioSource Corp.
    Panelists: Hans-Georg Eichler, Sr. Medical Officer, European Medicines Agency; Carole Longson, PhD, Director, Centre for Health Technology Evaluation, National Institute for Health and Clinical Excellence; Lise Rochaix, PhD, Prof., Commission d'evaluation economique et de sante publique (CEESP), Haute Autorite de Sante; Ansgar Hebborn, PhD, Head - Global Payer & HTA Program Policy, F. Hoffmann-LaRoche AG

    IP20: Identifying and Characterizing Heterogeneity in Treatment Response: Interesting Intellectual Exercise or Valuable For Drug Development, Reimbursement, and Personalized Medicine?
    Moderator: Kerstin Uhl-Hochgraeber, MD, Head, GHEOR Women's Health and Diagnostic Imaging, Bayer Schering Pharma AG
    Panelists: Donald E. Stull, PhD, Sr. Research Scientist, United BioSource Corp.; Kathleen W. Wyrwich, PhD, Sr. Research Leader, Center for Health Outcomes Research, United BioSource Corp.


    PODIUM PRESENTATION
    Mon., 8 Nov., 15:15 - 16:15 SESSION II

    MT3: Comparative Effectiveness of Anti-Depressants (AD) in the Treatment of the Elderly with Major Depressive Disorder (MDD): A Mixed Treatment Comparison and Meta-Regression Analysis
    Benedict A, Naci H, Fahrbach K, Bozkaya D, Happich M, Deberdt W, Raskin J


    POSTER PRESENTATIONS
    Sun., 7 Nov., 12:00 - 20:00 SESSION I

    PDB12:     Time to Opioid Use Among Commercially-Insured Patients with Diabetic Peripheral Neuropathic Pain Who Initiated Duloxetine Versus Other Treatments - a Propensity Score Approach
    Zhao Y, Wu N, Chen SY, Fraser K, Boulanger L

    PRS50: Employing Multi-Attribute Utility Theory to Develop the EXACT-U: A Preference-Based Measure for COPD Exacerbation Utilities
    Petrillo J, Cairns J, Revicki DA

    Mon., 8 Nov., 8:00 - 19:00 SESSION II

    PMC7: Tariff Lists From Spanish Autonomous Communities: An Assessment of Its Structure, Contents, and Tariff Levels
    DeCock E, Raluy M, Rovira J

    PMC18: Multi-National Chart Review Studies in Europe: Opportunities and Challenges
    Payne KA, Wasiak R, Stein D, Chancellor J

    PCV32: Budget Impact Analysis of Paclitaxel Drug Eluting Stent (DES) for the Treatment of Lower Limb Peripheral Arterial Disease (PAD) in France
    Lopes S, DeCock E

    PCV73: Economic Evaluation of Combination Therapy for Hypertension in High Risk Patients in Sweden
    Brown R, Brede Y, Getsios D, Tambour M, Falvey H

    PCV107: Valuation of Health State Utilities Related to Cardiovascular Prevention with Aspirin
    Manson SC, van Hanswijck de Jonge P, Palsgrove A, Gorelick PB

    PIH10: Treatment and Cost for Patients with Endometriosis in the United Kingdom
    Wasiak R, Manson S, Ryan J, Petri JC

    PIH35: Demonstrating Conceptual Equivalence Across Multiple Cultures: Translation and Linguistic Validation of the IPAQ
    Arnold BJ, Kimel M, Goddard A, McCormack J, Parks-Vernizzi E, Dhar J, Pleil A

    PIH40: Methodological Considerations When Assessing Work Productivity (WP) and Activities of Daily Living (ADL) Outcomes in Multinational Clinical Trials in Women with Heavy and/or Prolonged Menstrual Bleeding (HPMB) Treated with Estradiol Valerate/Dienogest (E2V/DNG)
    Wasiak R, Filonenko A, Stull DE, Kreif N, Raluy M, Ryan J, Jeddi M, Uhl-Hochgraber K, Vanness D

    PIH61: Calibration of a Discrete Event Simulation Model of Natural History of HPV-Related Diseases
    Quon P, Vanness DJ, Kansal A, Hillemanns P, Remy V, Quilici S

    PND5: Budget-Impact Model to Test Effects of Changing Rufinamide Tier Status From a Payer Perspective
    Powers A, Faria C, Buchner D, Shaul A, Cragin L

    PND16: Modeling the Clinical and Economic Implications of Galantamine in the Treatment of Mild to Moderate Alzheimer's Disease in Germany
    Guo S, Hernandez L, Wasiak R, Gaudig M

    Tues., 9 Nov., 11:00 - 12:00 SESSION III

    PIN10:     Cost Versus DRG Revenue Implications of Treating a Patient with Ventilator-Associated Pneumonia (VAP) with Doripenem Versus Imipenem in Germany
    DeCock E, Gast C, Berndt K, Kubitz N

    PIN67: Modelling G-DRG Revenue When Hospitalisation Duration From Clinical Trials is Available: The Case of Doripenem Versus Imipenem in Treating Ventilator-Associated Pneumonia (VAP) in Germany
    DeCock E, Gast C, Berndt K, Kubitz N

    PSY4: Biological Agents for the Treatment of Nail Psoriasis: A Systematic Review of the Literature
    Naci H, Green J, Prasad M, Fleurence R

    PSY38: Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
    Muszbek N, Punekar Y, Buchanan J, Prasad M, Vioix H, Brown R

    PSY52: Development and Content Validation of a Multicentric Castlemans Disease Symptom Scale
    Teschendorf B, Vernon M, O'Quinn S, van Rhee F

    PUK27: Time Savings with Q4W (Once-Monthly) C.E.R.A.: A Time and Motion Study Conducted in Haemodialysis Centres in Five European Countries
    Raluy M, Irgl H, DeCock E

    PUK32: Content Validity of a Patient-Reported Urinary Urgency Rating Scale: Results of a Cognitive Interview Study
    Chen WH, Notte S, Marshall TS, Lee M, Hakimi Z, Revicki DA

    PUK33: Test-Retest Reliability and Acclimation Effect of Patient Perception of Intensity of Urgency Scale (PPIUS) for Overactive Bladder
    Chen WH, Notte S, Marshall TS, Lee M, Hakimi Z, Revicki DA

  • ISOQOL 17th Annual Conference

    Oct 27 - Oct 30 2010
    London, England
    www.isoqol.org/

    SYMPOSIA
    Thurs., Oct. 28, 2:00 p.m. - 3:30 p.m.

    Symposium Title: Development and Comparisons of Alternative Preference-Based Measures of Health
    Steven B. Clauser, National Cancer Institute; John Brazier, Sheffield School of Health and Related Research; David Feeny, Kaiser Permanente Northwest; Dennis A. Revicki, United BioSource Corp.; Paul Kind, University of York

    Health Preference Assessment in the PROMIS Project: Estimation and Variation in Preference Scores by Demographic and Disease Groups
    Revicki DA

    Fri., Oct. 29, 2:00 p.m. - 3:30 p.m.

    Symposium Title: Current Methods for Measuring and Valuing Health States: Methodological Issues and Policy Implications
    William Lenderking, United BioSource Corp.; Rick Berzon; Dominique Dubois; John Brazier, Sheffield School of Health and Related Research; Alan Haycox

    Methodology Regarding Valuing and Measuring Health States
    Lenderking W


    EDUCATIONAL WORKSHOPS
    Wed., Oct. 27, 9:00 a.m. - 12:00 p.m.

    W5: Interpretation of PRO Data Within Clinical Trials
    Instructors: Josephine Norquist, MS, Merck, Sharpe & Dohme; Kathleen Wyrwich, PhD, United BioSource Corp.

    W7: Advanced Psychometric Methods, Part 1: Use of Exploratory and Confirmatory Factor Analyses in PRO Instrument Development and Evaluation
    Instructors: Donald Stull, PhD, United BioSource Corp.; Margaret Vernon, PhD, United BioSource Corp.

    Wed., Oct. 27, 1:00 p.m. - 4:00 p.m.

    W13: Advanced Psychometric Methods, Part 2: Executing and Interpreting Exploratory and Confirmatory
    Instructors: Donald Stull, PhD, United BioSource Corp.; Margaret Vernon, PhD, United BioSource Corp.

    W15: Innovative Methods for Electronically Capturing Patient-Reported Outcomes and Preference Data in Non-Interventional Studies
    Instructors: Ingela Wiklund, PhD, United BioSource Corp.; Karin Coyne, PhD, United BioSource Corp.; Shae Wilkins, Arrowhead Electronic Healthcare


    ORAL PRESENTATIONS
    Thurs., Oct. 28, 11:30 a.m.

    Item Identification for the EXACT-U: A Preference-Based Measure to Report Utilities for COPD Exacerbations.
    Petrillo J, Cairns J, Lamping D, Jones P

    Fri., Oct. 29, 11:30 a.m.

    Copyright of Translations of PRO Measures: Rules and Applications
    Anfray C, Conway K, Acquadro C, Eremenco S

    POSTER PRESENTATIONS
    Assessment of Unidimensionality for the Visual Function Questionnaire-Utility Index (VFQ-UI) Items in Patients with Central Vision Loss
    Revicki DA, Rentz AM, Kowalski JW, Chen WH

    Development of an Excessive Daytime Sleepiness Diary
    Norquist JM, Vernon MK, O'Quinn S, McQuarrie K, Dinges D, Roth T, Herring W, Brodovicz GH

    Development of the U.S. National Frequent Heartburn Index (FHBI) and Associated Composite Score
    Stull D, Houghton K, van Hanswijck de Jonge P, Kocun C, Sandor DA

    Patient-Reported Outcome Instruments Used to Assess Pain and Functioning in Studies of Treatment for Bone Metastases
    Matza LS, Fallowfield L, Chung K, Currie BM, Van Brunt K, Patrick DL

  • 2010 RAPS Annual Conference & Exhibition

    Oct 24 - Oct 27 2010
    San Jose, CA
    www.raps.org/


    PRESENTATION
    REMS: Theory, Practice, Evolution
    Kelly Davis, MD, Vice President, Safety Epidemiology and Risk Management, United BioSource Corporation; David Feigal, Jr., MD, MPH, Principal, NDA Partners LLP; Florence Houn, MPH, MD, Vice President, Regulatory Policy and Strategy, Celgene Corporation; Raj Kishore, PhD, Principal, Regulatory Strategy, Quintiles Consulting

  • American Society for Reproductive Medicine (ASRM) 66th Annual Meeting

    Oct 23 - Oct 27 2010
    Denver, CO, USA
    www.asrm.org/annualmeeting.aspx

    POSTER PRESENTATION
    Impact of Estradiol Valerate / Dienogest (E2V / DNG) on Work Productivity (WP) and Activities of Daily Living (ADL) Impairment in North American Women with Heavy and / or Prolonged Menstrual Bleeding (HPMP)
    Wasiak R, Filonenko A, Jensen JT, Law AW, Jeddi M, Stull DE

  • 48th Annual Meeting of the Infectious Disease Society of America (IDSA)

    Oct 21 - Oct 24 2010
    Vancouver, Canada
    www.idsociety.org/

    PRESENTATION
    Complicated Skin and Soft Tissue Infections (cSSTI) in Hospitalized Patients - a Prospective Multi-Center Observational Study of Clinical Characteristics and Medical Treatment
    Lipsky BA, Napolitano L, Moran GJ, Vo L, Nicholson S, Freier K, Boulanger L, Kim M

  • AdvaMed 2010

    Oct 18 - Oct 20 2010
    Washington, DC, USA
    www.advamed2010.com/

    EDUCATIONAL PANEL DISCUSSION
    Wed., Oct. 20, 9:00 a.m. - 10:15 a.m.

    Panel Location: 207A  Medical Affairs: Adding Value in Today's Global Medical Devices Industry
    Moderator: Ross Segan, MD, FACS, VP, Global Medical Affairs, Deputy Chief Medical Officer, Covidien
    Panelists: Peter Heeckt, MD, Chief Medical Officer, Smith & Nephew Orthopaedics; Greg de Lissovoy, PhD, MPH, Vice President for Health Technology, United BioSource Corp.

  • Third Annual Risk Management and Drug Safety Summit

    Oct 18 - Oct 19 2010
    Washington, DC, USA
    www.fdanews.com/conference/detail?eventId=2920


    CONFERENCE CO-CHAIR
    Annette Stemhagen, DrPH, FISPE, SVP Safety, Epidemiology, Registries & Risk Management, United BioSource Corp.

    SPEAKER
    REMS Evaluations: What Have We Learned?
    Kelly Davis, MD, VP Safety, Epidemiology & Risk Management, United BioSource Corp.

    PANEL DISCUSSIONS
    Reading the Drug Safety Tea Leaves - Top Legal and Compliance Challenges That Lie Ahead
    Panel Moderator: Mark Ammann, PharmD, VP, Regulatory Affairs, United BioSource Corp.
    Panelists: Gordon Johnston, VP Regulatory Sciences, Generic Pharmaceutical Association; Edward Fotsch, MD, CEO, PDR Network; Josephine Torrente, JD, Director, Hyman, Phelps & McNamara; Peter Pitts, Co-Founder, President, Center for Medicine in the Public Interest; Gerald Faich, MD, MPH, FISPE, SVP, Safety, Epidemiology, Registries & Risk Management, United BioSource Corp.

    REMS "Veterans" Share Their Battlefront Tales
    Panel Moderator: Patricia Fritz, VP, Govt. Affairs and Policy, UCB Inc.
    Panelists: Gerald Faich, MD, MPH, FISPE, SVP, Safety, Epidemiology, Registries & Risk Management, United BioSource Corp.; Carmen Bozic, MD, VP, Drug Safety & Risk Management, Biogen Idec; Gary Friedman, MD, Medical Director, Novartis Pharmaceuticals; Bob Anders, PharmD, VP, U.S. Processes & Systems, Lundbeck; Christopher Pitcherella, External Provider Management Team Leader, AstraZeneca

  • AMCP's 2010 Educational Conference

    Oct 13 - Oct 15 2010
    St. Louis, MO, USA
    www.amcp.org/conferences/2010/stlouis/index.cfm


    POSTER PRESENTATIONS
    Healthcare Resource Use and Costs Among Chronic and Episodic Migraine in the United States
    Stokes M, Varon SF, Sullivan S, Blumenfeld A, Lipton RB, Goadsby PJ, Wilcox TK

    Acute Medication Use Among Americans with Chronic and Episodic Migraine
    Lipton RB, Varon SF, Goadsby PJ, Buse DC, Kawata AK, Wilcox TK, Blumenfeld A

    Preventive Medication Use Among Americans with Chronic and Episodic Migraine
    Blumenfeld A, Kawata AK, Goadsby PJ, Buse DC, Wilcox TK, Varon SF, Lipton RB

  • 35th Annual European Society of Medical Oncology (ESMO) Congress

    Oct 8 - Oct 12 2010
    Milan, Italy
    www.esmo.org/

    POSTER PRESENTATION
    Health-Related Quality of Life (HRQL) Outcomes of Ipilimumab Treatment in Patients with Previously Treated Unresectable Stage III or IV Melanoma (USIII/IV Mel)
    Revicki D, Kotapati S, van den Eertwegh A, Lorigan Paul, Linette G, Ottensmeier CH, Lebbe C, Messina M, Abdallah K, Wagner S

  • AUGS 31st Annual Scientific Meeting

    Sep 29 - Oct 2 2010
    Long Beach, CA
    /www.augs.org/


    POSTER PRESENTATION
    Responsiveness and Discriminant Validity of the PISQ-12 Questionnaire in Vaginal Prolapse Repair Using a Lightweight Mesh System
    Sikirica V, Gelhorn H, Coyne K, Gauld J, Robinson D

  • Visiongain 9th Annual Pricing and Reimbursement Conference

    Sep 28 - Sep 29 2010
    London, UK
    www.visiongain.com/Conference/272/9th-Annual-Pricing-and-Reimbursement

    ORAL PRESENTATION
    Wed., 29 Sept., 15:10

    Pricing, Reimbursement and Market Access Strategies for Orphan Medicines
    Speaker: Adam Barak, Head, International Pricing and Reimbursement, United BioSource Corp.

  • CBI's 13th Registries and Post-Approval Studies Congress

    Sep 28 - Sep 30 2010
    Princeton, NJ, USA
    www.cbinet.com/show_conference.cfm?confCode=PC10155

    ORAL PRESENTATIONS
    Strategic Considerations
    Chris Pashos, PhD, Vice President, United BioSource Corp.

    Methodological Considerations
    Krista Payne, MEd, Director and Research Scientist, Health Care Data Capture, United BioSource Corp.

    Ensuring Post-Approval Studies are Operationalized to Fulfill Their Multiple Purposes
    David C. Hufner, Clinical Program Director, United BioSource Corp.

  • EFNS Geneva 2010, 14th Congress of the European Federation of Neurological Societies

    Sep 25 - Sep 28 2010
    Geneva, Switzerland
    efns2010.efns.org/

    ORAL PRESENTATION
    Health-Related Quality of Life (HRQoL) Among Subjects with Chronic Migraine (CM) and Episodic Migraine (EM) in Five European Countries
    Kawata A, Varon S, Blumenfeld A, Lipton R, Wilcox T, Goadsby P

    POSTER PRESENTATION
    Comparing EuroQol-5 Dimensions (EQ-5D) Index Scores Between Subjects with Chronic Migraine (CM) and Episodic Migraine (EM) in Five European Countries and with Other Chronic Diseases
    Kawata A, Maglinte G, Doan Q, Lipton R, Wilcox T, Blumenfeld A, Goadsby P

  • 2010 FDA / Industry Statistics Workshop

    Sep 20 - Sep 22 2010
    Washington, DC, USA
    www.amstat.org/meetings/fdaworkshop/index.cfm?fuseaction=main

    SHORT COURSE
    Mon., Sept. 20, 8:30 a.m. - 12:00 p.m., Room C

    SC3: Interpreting Change and Responder Analyses for Patient-reported Outcomes
    Instructors: Joe Cappelleri, Pfizer; Lisa A. Kammerman, FDA; Kathleen W. Wyrwich, United BioSource Corp.


    PANEL DISCUSSIONS
    Wed., Sept. 22, 10:00 a.m. - 11:15 a.m., Room C

    PS5c: Heterogeneity in Treatment Response: What It Is, Why It's Important and How to Find It
    Presenters: Heterogeneity Issue in Clinical Trial, Chul Ahn, FDA/CDRH; Examining Heterogeneity in Treatement Response in Clinical Trials: The Poor Man's Mixture Model Analysis, Kathleen Wyrwich, United BioSource Corp.; Examining Heterogeneity in Treatment Response in Clinical Trials: Use of Factor Mixture Models, Donald E. Stull, United BioSource Corp.

    Wed., Sept 22, 12:45 p.m. - 2:00 p.m., Room C

    PS6c: Quantitative Assessments of Patient Reported Outcomes: Questionnaire Design and Analysis
    Discussants: Rima Izem, FDA/CDER/OB/DB4; Margaret Rothman, Johnson & Johnson; Kathleen Wyrwich, United BioSource Corp.

  • ERS Barcelona 2010

    Sep 18 - Sep 22 2010
    Barcelona, Spain
    www.erscongress2010.org/

    POSTER
    Evaluation of COPD Exacerbations Using the EXACT-U.
    Petrillo J, Cairns J

  • Congres International D'Epidemiologie

    Sep 15 - Sep 17 2010
    Marseille, France
    etudes.isped.u-bordeaux2.fr/ADELF2010_MARSEILLE/

    PRESENTATION
    Disability, HRQOL, HRU in France
    Lanteri-Minet M, Lipton R, Kawata AK, Velard ME, Varon SF, Goadsby P

  • JSCNP (Japan Society for Neuropsychopharmacology)

    Sep 15 - Sep 17 2010
    Sendai, Japan
    www.jscnp.org/en/annualmeeting/index.html

    POSTER PRESENTATION
    Improving Data Quality Throughout the Course of Alzheimer's Trials
    D Miller, C McNamara, S Podolin

  • ISPOR 4th Asia-Pacific Conference

    Sep 5 - Sep 7 2010
    Phuket, Thailand
    www.ispor.org/


    ISSUE PANEL AND WORKSHOPS
    Tues., Sept. 7, 11 a.m. - 12 p.m. - Session II

    IP4:     Risk-Sharing Schemes in the Asian Marketplace: What are the Steps for Success?
    Moderator: Lisbet Coulton, Director, International Pricing and Reimbursement, United BioSource Corporation
    Panelists: Abdulkadir Keskinaslan, MD, MBA, MPH, Market Pricing Director Asia, Novartis Pharma AG; Nathorn Chaiyakunapruk, PharmD, PhD, Associate Professor, Center of Pharmaceutical Outcomes Research, Naresuan Univ.; Wen Chen, PhD, Professor, Center for Pharmacoeconomic Research and Evaluation, Fudan Univ.
     
    W8:     The New German Methods for Economic Evaluation and Their Applicability in Asia
    Discussion Leaders: J. Jaime Caro, MD, Senior Vice President of Health Economics, United BioSource Corporation; Charalabos-Markos Dintsios, MPH, MA, Scientific Staff Department of Health Economics, Institute for Quality and Efficiency in Health Care (IQWiG); Anja Schwalm, MSc, Health Economist, Institute for Quality and Efficiency in Health Care (IQWiG); Isao Kamae, MD, DrPH, Professor of Pharmacoeconomics, JPMA Research and Education Project, Keio Univ.


    POSTER PRESENTATIONS
    Mon. and Tues., Sept. 6 and 7, 8 a.m. - 9 p.m. and 8 a.m. - 6:00 p.m.

    PCV18: Economic Evaluation of Using High-Dose Atorvastatin for the Prevention of Recurrent Stroke: Evidence from Thailand
    Suwanwela N, Kongnakorn T, Leartsakulpanitch J

    PHP15: Risk-Sharing Schemes Worldwide: A Landscape Analysis of Health Outcomes-Based Reimbursement Agreements
    Coulton L, Annemans L, Javier J, Brown R, Keskinaslan A

  • 7th International Conference on Prevention of Work-Related Musculoskeletal Disorders

    Aug 29 - Sep 3 2010
    Angers, France
    www.premus2010.org/index.html

    POSTER PRESENTATION
    Recurrence of Low Back Pain: Injured Workers' Perspectives
    Young AE, Wasiak R, Phillips LA, Gross DP

  • ECNP (European Collegium of Neuropsychopharmacology)

    Aug 28 - Sep 1 2010
    Amsterdam, The Netherlands
    www.ecnp.eu/emc.asp?pageId=1516

    POSTER PRESENTATIONS
    Issues and Opportunities in Cognitive Psychopharmacology Trials in Children
    K Wesnes, H Brooker

    The Profile of Attentional Deficits in Schizophrenia: Implications for Pharmacotherapy
    K Wesnes, H Brooker, C Edgar

  • ICS/IUGA 2010

    Aug 23 - Aug 27 2010
    Toronto, Canada
    www.icsoffice.org/

    Poster
    Validation of the Patient Global Impression of Change (PGIC) in a Patient Population Following Vaginal Prolapse Repair with Mesh
    Coyne K, Sikirica V, Gelhorn H, Robinson D, Hinoul P, Gauld J

  • 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

    Aug 19 - Aug 22 2010
    Brighton, UK
    www.pharmacoepi.org/meetings/26thconf/

    Workshop
    Guidance Regarding the Identification, Development, Validation and Translation of Coding Algorithms in Electronic Healthcare (EH) Databases
    Mehta V, Locasale RJ, Reynolds MW, Bohn RL, Trifiro G, Mark TL

    Oral Presentation
    Liver Function Test Abnormalities in Patients Treated with Small Molecule Tyrosine Kinase Inhibitors
    Nordstrom B

    Poster Presentations
    Characteristics of Patients Receiving Varenicline Treatment for Smoking Cessation in UK Primary Care: A THIN Database Study
    Blak BT, Wilson K, Metcalfe M, Maguire A, Hards M

    Global Prevalence of Pregnancy Outcomes
    Neibauer MW, Reynolds MW, Michels SL, Collins J

    Impact of Comorbidites on the Burden for Patients with Parkinson's Disease
    Ward A, Michels SL, Lanes S, O'Neill NG, Papapetropoulos S

    Parameterizing Risk-Benefit Models from Primary Care Data: Recurrence and Exacerbation
    Maguire A, Blak B, Haynes K

    Systematic Literature Review and Meta-Analysis of Apolipoprotein E e4 Prevalence in Alzheimer's Disease Patients
    Crean SM, Ward A, Mercaldi CJ, Collins JM, Cook MC, Baker NL, Arrighi HM

    Validation of ICD-9-CM codes to Identify Gastrointestinal Perforation Cases in Administrative Claims Data in Rheumatoid Arthritis Patients
    Curtis JR, Chen SY, Werther W, John A, Johnson D

  • ICAD (International Conference on Alzheimer's Disease) 2010

    Jul 10 - Jul 15 2010
    Honolulu, HI, USA
    www.alz.org/icad/overview.asp


    Workshop
    Advancing Measurement of Cognition in Clinical Trials
    Frank L, Miller D, Tractenberg R, Hobart J, Gauthier S, Black R, Landen J, Iwatsubo T

    Poster Presentations
    Systematic Literature Review and Meta-Analysis of Apolipoprotein E e4 Prevalence in Alzheimer's Disease Patients
    Arrighi HA, Crean SM, Ward A, Mercaldi CJ, Collins JM, Cook MN, Baker NL

    Attentional Deficits in the Dementias: Behavioural and Treatment Implications
    Wesnes K, Edgar C, Brooker H

    Training and Surveillance Considerations When Utilizing Expanded Versions of the ADAS-Cog
    Miller D, McClellan R, Siemers E

  • 8th European Conference on Health Economics

    Jul 7 - Jul 10 2010
    Helsinki, Finland
    www.eche2010.fi/

    Presentation

    Comparison of the Statistical Inference and Multi-Attribute Utility Theory Models to Develop a Preference-Based Instrument: The EXACT-U as a Case Study
    Petrillo J

  • 26th International Papillomavirus Conference

    Jul 3 - Jul 8 2010
    Montreal, Canada
    hpv2010.org/main/

    Poster
    A Discrete Event Simulation Approach in Modeling the Impact of HPV Vaccination and Cervical Cancer Screening
    Quon P, Vanness D, Hillemanns P, Largeron N, Remy V

  • Spanish Health Association (AES) XXX Conference on Health Economics

    Jun 22 - Jun 25 2010
    Valencia, Spain
    www.portalferias.com/jornadas-de-economia-de-la-salud-2010-valencia-espana_3282.htm

    Poster Presentation
    Use of Tariff Lists from Spanish Autonomous Communities for Economic Evaluations in Spain
    Raluy Callado M, De Cock E, Rovira J

  • NCDEU (New Clinical Drug Evaluation Unit) 2010

    Jun 14 - Jun 17 2010
    Boca Raton, FL, USA
    www.ncdeumeeting.org/NCDEU%202010.htm


    Panel
    Novel and Emerging Endpoints in Child Psychopharmacology Research
    Busner J,  Vitiello B, Greenhill, Wesnes K, Kotagal S

    Workshop
    Methodological Issues for Studying Negative Symptoms of Schizophrenia
    Daniel D, Marder S

    Poster
    Doctorate Level US PANSS Raters Score Higher on a Measure of Interview Quality than Non-doctorate Level Raters
    Daniel D

    Poster
    Improvements to Cognitive and Visuo-Perceptual Task Performance in Dementia with Lewy Bodies Galantamine
    Edgar C, Wesnes K, Zangar A, Edwards K

    Poster
    The Implications of the Cognitive Deficit Profile in Schizophrenia for Therapeutic Strategies
    Wesnes K, Brooker H, Hassman H, Edgar C, Daniel D

  • MDS (Movement Disorders Society) International Congress

    Jun 13 - Jun 17 2010
    Buenos Aires, Argentina
    www.movementdisorders.org/congress/congress10/
    Poster
    Does the Addition of New Raters to a Parkinson's Disease Clinical Trial Result in Increased Noise?
    Kott A, Miller D, McClellan R

  • DIA 46th Annual Meeting

    Jun 13 - Jun 17 2010
    Washington, DC, USA
    www.diahome.org

    Panel Sessions

    Can a Risk Management Program Save a Product from Withdrawal?
    Session Chairperson: Gerald A. Faich, MD, MPH, Senior Vice President, SERRM, United BioSource Corporation
    Panel Speakers: The Tysabri Experience - Representative Invited, Vice President, Global Head, Drug Safety and Risk Management, Biogen; Inhaled Insulin - Anders H. Boss, MD, FFPM, Chief Medical Officer, MannKind Corporation; FDA Point of View - Gerald J. Dal Pan, MD, MPH, Director, Office of Surveillance and Epidemiology, CDER, FDA

    Document Preparation When You're Short on Time
    Session Chairperson: Laura Webb, BSN, RN, President, WebbWrites
    Panel Speakers: Key Performance Indicators for Medical Writing: Fact or Fantasy? - Michael D. Hoffman, MS, Senior Director, Medical Writing and Regulatory Operations, United BioSource Corporation; Statisticians and Writers: Effective Ways to Work Together to Save Time - Rebecca Drummond, PhD, Principal Biostatistician, Lundbeck; So Many Documents, So Little Time, So Little Time - Laura Webb, BSN, RN, President, WebbWrites

    Incorporating Risk Management Strategies Into Premarketing Clinical Trials
    Session Chairperson: Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries and Risk Management, United BioSource Corporation
    Panel Speaker: Translating Premarket Risk Assessments into Postmarketing Risk Management Programs - Mwango Kashoki, MD, MPH, Associate Director, Safety, Office of New Drugs, CDER, FDA

    Innovations in Combining Patient-reported Outcomes with Physiologic Measurements to Leverage Real-time Access to Data
    Session Chairperson: Christina Curry, MSc
    Panel Speakers: Innovations in Physiologic and Patient-reported Data Capture: Implications for Streamlining Data Collection and Leveraging Access to Real-time Data - Sonya L. Eremenco, MA, ePRO Manager, United BioSource Corporation; Innovations in Oncology Symptom Data Capture: PROs versus ClinROs - Ethan M. Basch, MD, Medical Oncologist; Memorial Sloan-Kettering Cancer Center; Innovations in Cognitive Testing: Using ePRO to Assess Drug Effect - Christina Curry, MSc, Marketing Specialist, PHT Corporation

    Patient Recruitment in a Technological Era
    Session Chairperson: Richard J. Mayewski, Global Trial Optimization Specialist, Merck & Co.
    Panel Speakers: Patient Recruitment 2.0: Making the Case for Technological Adoption - Joseph Kim, MBA, MEd, Director, Site Feasibility and Patient Recruitment, ePharmaSolutions; Is TV Advertising Old School? Leveraging the Digital Age for Effective Clinical Trial Patient Recruitment and Retention - Abbe Steel, Executive Director, United BioSource Corporation; Determining the Best Way to Reach and Support Patients in a Technological Era - Tim Davis, CEO and Co-founder, Exco InTouch

    Payer Perspectives of Evidence-based Medicine and Comparative Effectiveness: Making Evidence Matter in the Marketplace
    Session Chairperson: Craig A. Hunter, MPP, PGDP, Senior Science Policy Analyst & Senior Manager, Science Policy, United BioSource Corporation

    Personalized Medicine: Are We There Yet?
    Session Chairperson: Georgia Mitsi, PhD, MBA, MSc, Senior Research Associate, United BioSource Corporation
    Panel Speakers: Personalized Medicine: FDA Perspective - Francis Kalush, PhD, Network Leader, Diagnostics and Personalized Medicine, FDA

    Qualification of Patient-Reported Outcome (PRO) Tools to Support Labeling Claims: Development, Evaluation, and a Consortium Approach
    Session Chairperson: Laurie Burke, MPH, RPh, Assistant Director, Study Endpoints and Label Development, CDER, FDA
    Panel Speakers: FDA Evaluation of PRO Measures for Regulatory Qualification to Support Claims - Elektra J. Papadopoulos, DrMed, Medical Officer, FDA; Development and Documentation of PRO Tools for Regulatory Review -  Nancy Kline Leidy, PhD, Senior Vice President, Scientific Affairs, United BioSource Corporation; The Patient-reported Outcomes (PRO) Consortium: A Public-private Partnership Approach - Stephen Joel Coons, PhD, MEd, MSc, Director, PRO Consortium, Critical Path Institute

    REMS Evalutions: What Have We Learned?
    Session Chairperson: Kelly D. Davis, MD, Vice President, Safety, Epidemiology and Risk Management, United BioSource Corporation
    Panel Speakers: Development of the REMS Assessment Plan - Kelly D. Davis, MD, Vice President, Safety, Epidemiology and Risk Managment, United BioSource Corporation; REMS KAB Survey Design: Did the Patients and HCPs Get the Message? - Kala L. Paul, MD, MS, President, The Corvallis Group; FDA's Perspective on the First Round of REMS Evaluation Results - Mary Willy, PhD, Senior Risk Management Analyst, Team Leader, CDER, FDA

    What Deliverable? Importance of Close Collaboration Between Data Management and Other Functions
    Session Chairperson: Teresa Ancukiewicz, MA
    Panel Speakers: Statistical Programmers: What They Do and How They Can Help - Carol Matthews, Senior Director, Clinical Programming, United BioSource Corporation; What Deliverable? Importance of Close Collaboration Between Data Management and Biostatistics Teams - Zia Haque, MA, Associate Director, Data Management, Pharmanet Development Group

  • 15th Congress of the European Hematology Association (EHA)

    Jun 10 - Jun 13 2010
    Barcelona, Spain
    www.ehaweb.org/

    Poster
    Impact of Lenalidomide on Health-Related Quality of Life in Patients with RBC Transfusion-Dependent Low- or Int-1-Risk Myelodysplastic Syndromes with del(5q): A Randomized Phase 3 Study (MDS-004)
    Brandenburg N, Fu T, Revicki D, Knight R, Muus P, Fenaux P

  • Canadian Neurological Sciences Foundation (CNSF) 45th Annual Congress

    Jun 8 - Jun 11 2010
    Quebec City, Quebec, Canada
    www.ccns.org/congress_program.html

    Poster
    Migraine-Related Disability, Work Impact and Quality of Life (QOL) Among Canadians with Chronic and Episodic Migraine
    Becker W, Wilcox T, Wells L, Blumenfeld A, Kawata A, Varon S, Lipton R

    Podium Presentation
    Headache Severity, Comorbidities, and Healthcare Resource Utilization Among Chronic Migraine and Episodic Migraine in Canada
    Becker W, Kawata A, Yeomans K, Varon S, Lipton R, Wells L, Blumenfeld A

  • CINP (Collegium Internationale Neuro-Psychopharmacologicum) 2010 World Congress

    Jun 6 - Jun 10 2010
    Hong Kong, China

    Symposium
    Conducting Clinical Trials in Asia
    Daniel D, Hua J, et al.

  • HTAi 7th Annual Meeting Dublin 2010

    Jun 6 - Jun 9 2010
    Dublin, Ireland
    www.htai2010.org

    Oral Presentations
    Finding Ways to Make Outcomes Assessments Effective in Risk-sharing Agreements
    Coulton L, Keskinaslan A, Annemans L, Javier J

    HTA When There are No Direct Comparative Effectiveness Data: PARTS
    Caro JJ, Khan Z

  • ASCO 2010 Annual Meeting

    Jun 4 - Jun 8 2010
    Chicago, IL, USA
    www.asco.org/

    Presentation
    Burden of Illness Estimates of Metastatic Breast Cancer (MBC) in the United States
    Sorensen S, Benedict A, Yardley D, Martin M, Knopf K, Pan F, Goh J, Giorgetti C, Chen C

    Economic Analysis of DecitabineVersus Best Supportive Care in the Treatment of Intermediate and High Risk Myelodysplastic Syndromes (MDS).
    Kim E, Pan F, Peng S, Fleurence R

  • World Ophthalmology Congress 2010 (WOC 2010)

    Jun 3 - Jun 9 2010
    Berlin, Germany
    www.woc2010.org

    Oral Presentations
    Effect of Dexamethasone Intravitreal Implant on Patient-Reported Visual Functioning for the Treatment of Macular Edema Following Retinal Vein Occlusion
    Kowalski J, Rentz A, Revicki D, Bandello F, Gillies M, Yoon Y, Liu C, Whitcup SM

    Normative Comparison of Generic- and Vision-Targeted Health-Related Quality of Life (HRQL) Outcomes in Patients with Vision Loss Due to Macular Edema Following Retinal Vein Occlusion
    Rentz A, Kowalski J, Revicki D, Lowenstein A, Whitcup SM

    Poster Presentation
    Efficacy of Dexamethasone Intravitreal Implant for the Treatment of Uveitis Based on Patient-Reported Vision Function Outcome Measures
    Kowalski J, Gelhorn H, Naik R, Cui H, Revicki D, Lowder CY, Belfort Jr R, Foster CS, Lightman S, Whitcup SM

  • Statisticians in the Pharmaceutical Industry (PSI) Meeting on Patient Reported Outcomes

    Jun 2 - Jun 2 2010
    London, UK
    www.psiweb.org/

    Oral Presentation
    Interpreting Change Over Time in Patient-Reported Outcomes
    Kathy Wyrwich, PhD, Senior Research Leader, Center for Health Outcomes, United BioSource Corporation

  • XI Congreso Nacional AEEM

    Jun 1 - Jun 4 2010
    Malaga, Spain
    www.meetandforum.net/aeem2010malaga/

    Presentation
    Evaluacion de la Calidad de Vida Relacionada con la Salud (HRQOL) en Mujeres Postmenopausicas que Participaron en el Estudio FREEDOM
    Palacios S, Siris E, Silverman S, Viswanathan H, Wang A, Qian Y, Ragi-Eis S, Fardellone P, Gilchrist N, Lips P, Nevitt M, Pavelka K, Revicki D, Simon J, Macarios D

  • 13th Biennial European Conference of the Society for Medical Decision Making (SMDM Europe 2010)

    May 30 - Jun 2 2010
    Hall in Tyrol, Austria
    www.smdm.org/index.shtml

    Poster
    A Discrete Event Simulation Approach in Modeling the Health and Economic Impact of HPV Vaccination and Cervical Cancer Screening
    Quon P, Vanness D, Hillemanns P, Largeron N, Remy V

  • CBI and ISOQOL's Forum on Patient Reported Outcomes

    May 25 - May 26 2010
    Philadelphia, PA, USA
    www.cbinet.com/

    Joint Forum Co-Chairs
    William Lenderking, PhD, Senior Research Scientist, United BioSource Corporation and Jeff Sloan, PhD, Lead Statistician, Mayo Clinic

    Tues. May 25
    3:30 p.m.

    Panel Discussion
    Influencing Commercial Market Research to Reflect Necessary PRO Concepts
    Moderator: Robert DiGregorio, DO, FACOOG, Director II, Regulatory Affairs, Pfizer
    Panelists: Jeff Sloan, PhD, Senior Statistician, Mayo Clinic; William Lenderking, PhD, Senior Research Scientist, United BioSource  Corporation

    Wed. May 26
    11:00 a.m.

    Oral Presentation
    A Significant Change in FDA's Final Guidance on Patient Reported Outcomes -- Interpretation
    Kathleen W. Wyrwich, PhD, Senior Research Leader, Center for Health Outcomes Research, United BioSource Corporation

  • APA (American Psychiatric Association) Annual

    May 22 - May 26 2010
    New Orleans, LA
    psych.org/MainMenu/EducationCareerDevelopment/Meetings/AnnualMeeting.aspx

    Workshop
    The Use of Research Instruments in Clinical Practice
    Busner J, Greco N, Kaplan S

    Poster
    Educational Quality of the Rater Predicts Quality of Symptom Assessment Interviews in Schizophrenia Trials
    Daniel D, Sartorius N, Bartko J

    Poster
    The Application of a Comparative Effectiveness Trial Criteria to a Commercially insured Population of Children with ADHD
    Busner J, Abousaid S, Durkin M, Schneider G

  • ISPOR 15th Annual International Meeting

    May 15 - May 19 2010
    Atlanta, GA, USA
    www.ispor.org


    EDUCATIONAL SYMPOSIUM

    Tues. May 18
    1:30 - 2:30 p.m.

    Comparative Effectiveness & Standards of Evidence: The Intersection of Science, Policy, Regulation and Business
    Moderator: Bryan R. Luce, PhD, MBA, Senior Vice President, United BioSource, Corporation
    Speakers:  Scott Gottlieb, MD, Resident Fellow, American Enterprise Institute; FDA Representative (invited), Director, Study Endpoints and Label Development, Center for Drug Evaluation and Research, Food and Drug Administration; Les Paul, MD, Vice President, Clinical & Scientific Affairs, National Pharmaceutical Council; Brian Sweet, RPh, MBA, Chief Pharmacy Officer, Wellpoint Inc.


    SHORT COURSES

    Sat. May 15
    8:00 a.m. - 5:00 p.m.

    Bayesian Analysis: Overview and Applications
    Faculty: David Vanness, PhD, Visiting Scientist, Center for Health Economics and Science Policy, United BioSource Corporation and Assistant Professor, University of Wisconsin School of Medicine and Public Health; Christopher S. Hollenbeak, PhD, Associate Professor, Surgery and Public Health Sciences, Penn State College of Medicine

    Sun. May 16
    8:00 a.m. - 5:00 p.m.

    Discrete Event Simulation for Economic Analyses
    Faculty: J. Jaime Caro, MDCM, FRCPC, FACP, Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatistics, McGill University & Senior Vice-President of Health Economics, United BioSource Corporation; Jörgen Möller, MSc Mech Eng, Vice President, Modeling, United BioSource Corporation

    Sun. May 16
    8:00 a.m. - 12:00 p.m.

    Bayesian Analysis - Advanced
    Faculty: Keith R. Abrams, PhD, Professor of Medical Statistics, Department of Health Sciences, University of Leicester; David Vanness, PhD, Visiting Scientist, Center for Health Economics and Science Policy, United BioSource Corporation and Assistant Professor, University of Wisconsin School of Medicine and Public Health; Christopher S. Hollenbeak, PhD,  Associate Professor, Surgery and Public Health Sciences, Penn State College of Medicine


    PLENARY SESSIONS

    Tues. May 18, Session II
    11:15 a.m. - 12:45 p.m.

    Is Health Outcomes Research Valuable to Real Decision Makers: A Candid Discussion with Medical and Pharmacy Directors
    Moderator: J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President of Health Economics, United BioSource Corporation

    Wed. May 19, Session III
    10:00 - 11:30 a.m.

    Bayesian and Adaptive Trial Methods Meets the Pragmatic Clinical Trial and Comparative Effectiveness Research
    Moderator: Bryan R. Luce, PhD, MBA, Senior Vice President, Science Policy, United BioSource Corporation


    ISSUE PANEL

    Tues. May 18, Session II
    2:45 - 3:45 p.m.

    Cost-Effectiveness Analysis in the Southwest Quadrant: Adopting Medical Technology That Costs Less and Does Less
    Moderator: Greg de Lissovoy, PhD, MPH, Senior Research Scientist and Vice President, Health Technology, Center for Health Economics, Epidemiology and Science Policy, United BioSource Corporation
    Panelists: Peter J. Neumann, ScD, Professor, Tufts University School of Medicine and Director, The Center for the Evaluation of Value and Risk in Health, The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center; John F.P. Bridges, PhD, Assistant Professor, Department of Health Policy and Management, Johns Hopkins University; David W. Lee, PhD, Senior Director, Health Economics - Americas, GE Healthcare


    WORKSHOPS

    Mon. May 17, Session II
    4:15 - 5:15 p.m.

    Interpretation of PRO Trial Results to Support FDA Labeling Claims
    Discussion Leaders: Kathleen W. Wyrwich, PhD, Senior Research Leader, Center for Health Outcomes Research, United BioSource Corporation; Laurie B. Burke, RPh, MPH, Director, Study Endpoints and Label Development, Center for Drug Evaluation and Research, Food and Drug Administration; Ann Marie Trentacosti, MD, Endpoints Reviewer, Study Endpoints and Label Development, Center for Drug Evaluation and Research, Food and Drug Administration

    Model Assumptions in Mixed Treatment Comparisons (MTCS): Why They Matter and Why You Should Care
    Discussion Leaders: Rachael Fleurence, PhD, Senior Research Scientist, Center for Health Economics and Science Policy, United BioSource Corporation; Kyle Fahrbach, PhD, Senior Biostatistician, United BioSource Corporation; David Vanness, PhD, Assistant Professor, Population Health Sciences, University of Wisconsin School of Medicine and Public Health

    What Can Resource Allocation in Situations of Extreme Scarcity Tell Us About the Role of the QALY in Priority Setting?
    Discussion Leaders: Peter Kolominsky-Rabas, PhD, MBA, Scientific Director, Interdisziplinäres Zentrum für Public Health (IZPH) der Universität Erlangen-Nürnberg; Georgia Mitsi, PhD, MBA, MSc, Manager, United BioSource Corporation; J. Jaime Caro, MD, Senior Vice President of Health Economics, United BioSource Corporation

    Tues. May 18, Session III
    4:00 - 5:00 p.m.

    Identifying and Projecting Product Value Through Early-Phase Clinical-Economic Modeling
    Discussion Leaders: Ipek Ozer-Stillman, MS, Research Scientist, United BioSource Corporation; J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President, United BioSource Corporation; Bjorn Bolinder, MBA, Head, Primary Care, Global Health Outcomes, Merck & Co.

    Strategies and Methods for Optimizing the Use of Outcomes Reported by Patients Along the Health Care Decision Making Continuum - From Regulators, to Health Technology Assessors, to Payers
    Discussion Leaders: Asha Hareendran, PhD, Senior Research Scientist, United BioSource Corporation; William Lenderking, PhD, Senior Research Leader, United BioSource Corporation; Lou Garrison, PhD, Professor, Pharmaceutical Outcomes Research & Policy Program, Department of Pharmacy, University of Washington

    Tues. May 18, Session IV
    5:15 - 6:15 p.m.

    When There is No Head-To-Head Trial: Using a PARTS Approach
    Discussion Leaders: Zeba Khan, PhD, Vice President, Pricing and Market Access, Celgene; J. Jaime Caro, MD, Senior Vice President of Health Economics, United BioSource Corporation

    Wed. May 19, Session V
    1:45 - 2:45 p.m.

    Enriching Budget Impact Models for U.S. Payers with Relevant Clincal Outcomes
    Discussion Leaders: Ipek Ozer-Stillman, MS, Research Scientist, United BioSource Corporation; John D. Whalen, Research Associate II, United BioSource Corporation; Bjorn Bolinder, MBA, Head, Primary Care, Global Health Outcomes, Merck & Co.

    Wed. May 19, Session VI
    3:00 - 4:00 p.m.

    Failure at the Mean: The Importance of Reflecting Heterogeneity in Economic Evaluations
    Discussion Leaders: Denis Getsios, Research Scientist, United BioSource Corporation; Phil McEwan, PhD, Managing Director, CRC

    The Use of Observational Evidence for Comparative Effectiveness Research: Is It Fit-For-Purpose?
    Discussion Leaders: Rachael Fleurence, PhD, Senior Research Scientist, Center for Health Economics and Science Policy, United BioSource Corporation; Kyle Fahrbach, PhD, Senior Biostatistician, United BioSource Corporation; David Vanness, PhD, Assistant Professor, Population Health Sciences, University of Wisconsin School of Medicine and Public Health


    PODIUM PRESENTATIONS

    Mon. May 17, Session I
    1:45 - 2:45 p.m.

    Accounting for the Relationship Between Per Diem Cost and LOS When Estimating Hospitalization Costs
    Stolar M, Hu MY, Ishak K, Wang Y, Williams GC, Ferguson J, Getsios D, Alvarez P

    Tues. May 18, Session III
    9:45 - 10:45 p.m.

    Perioperative Blood Pressure Control During Cardiac Surgery Reduces Hospitalization Costs
    Ishak K, Stolar M, Wang Y, Alvarez P, Hu MY, Williams GC, Ferguson J, Aronson S, Multz AS, Dyke CM, Getsios D


    POSTER PRESENTATIONS

    Mon. May 17, Session I
    8:00 a.m. - 8:30 p.m.

    A Systematic Review of Adherence, Quality of Life and Medical Costs in Fixed-Dose Combination Regimens in Diabetes
    Hutchins V, Krishnarajah G, Fleurence R

    Budget Impact Analysis of an Organized Breast Cancer Screening Program Based on Annual Mamography for Colombian Women
    Hernandez L, Castillo M

    Cost-Effectiveness Analysis of Bendamustine Compared to Alemtuzumab and Chlorambucil for Chronic Lymphocytic Leukemia in a Treatment-Naive Population
    Malin J, Kongnakorn T, Sterchele J, Salvador C, Getsios D, Mwamburi M

    Cost-Effectiveness Analysis of Sorafenib Versus Best Supportive Care (BSC) in Advanced Hepatocellular Carcinoma (AHCC): The Public Health Care System Perspective in Brazil
    Muszbek N, Munir U, Vioix H, Schiola A, Valderrama A, Teich V

    Methodologic Issues of Identifying Febrile Neutropenia Patients Using Medical Claims Data
    Michels SL    , Barron R

    Methods for Identifying Case Reports of Suspected Adverse Drug Reactions: An Evaluation of the Efficiency of Alternative Search Strategies in Medline and EMBASE
    Michels SL, Ward A, Jones N


    Tues. May 18, Session II
    8:00 a.m. - 8:00 p.m.

    The Comparative Efficacy of Injectable and Oral Atypical Antipsychotics in Reducing Relapses in Adult Schizophrenia Patients: A Systematic Review and Mixed Treatment Comparison Analysis
    Blume S, Naci H, Green J, Fleischmann J, Gaudig M

    Differences in Clinician Reported Ease of Use Between 2 Hemostasis Treatment Methods: Results From a Randomized Controlled Study
    Rupnow MF, McCormack J, Vernon M, Batiller J, Hammond J

    Effect of Equivalent and Non-Equivalent Substitution of Prescribed Drugs for Depression and Anxiety Disorders on Patients Treatment Adherence and Perception
    LaPensee K, Carson R, Werner P, Sexton CC, Gelhorn H, Stankus A, Erder H

    Impact of Bleeding-Related Complications and Blood Product Transfusions on Hospital Length of Stay and Costs in Inpatient Surgical Patients
    Stokes M, Ye X, Mercaldi K, Reynolds MW, Rupnow MF, Hammond J

    The Utilization of Parenteral Nutrition in the United States
    Liu FX, Mercaldi K, Turpin R

    Web-Surveys: Real World Evidence Gathering and Minimizing Uncertainty in Economic Models
    Mitsi G, Cragin L, Payne K, Yu R, Goh J


    Wed. May 19, Session III
    8:00 a.m. - 3:00 p.m.

    Cost-Analysis of Levofloxacin IV Compared to Other Guideline-Endorsed Therapies for Patients Hospitalized with Community-Acquired Pneumonia
    Kongnakorn T, Mody S, Li Q, Frei C, Raut M, Schein J

    Discrete Event Simulation of Cardiac Hospitals Performing Percutaneous Coronary Interventions
    Pei P, Kongnakorn T, Hernandez L, Bae JP, Ramaswamy K, Moller J

    Economic Evaluation of Ceftobiprole for the Treatment of Complicated Skin and Skin Structure Infections in the United States
    Kongnakorn T, Baker TM, Akhras K, Merchant S, Mwamburi M, Caro JJ

    Methods to Identify and Compare Bloodstream Infection Rates Among Patients Administered Parenteral Nutrition via Hospital Compounded vs. Premixed Multi-Chamber Bags
    Liu FX, Mercaldi K, Reynolds MW, Turpin R

    Systematic Review of the Economic Burden of Venous Thromboembolism Treatment
    Woodward TC, Kachroo S, Bookhart B, Chen J, Reynolds MW

    Translating the EXACT: Ensuring Conceptual Equivalence Across Multiple Cultures
    Arnold BJ, Murray L, Herzberg T, Roberts L, Leidy N

    Using Different Measures to Determine Time in Therapeutic INR Range Among Warfarin-Treated Patients Following Total Hip or Knee Replacement
    Nordstrom B, Kachroo S, Nutescu E, Schein J, Fisher A, Bookhart B

    Clinical-Economic Evaluation of Azacitidine Versus Decitabine For Treating Patients with Myelodysplastic Syndromes (MDS)
    Miller J, Fenaux P, Beach C.L., Gidwani R, Khan, Zeba

  • 2010 American Thoracic Society (ATS) International Conference

    May 14 - May 19 2010
    New Orleans, LA, USA
    www.thoracic.org

    Oral Presentations
    Session Title    : Celebrating the 25th Anniversary of the National Institute of Nursing Research (NINR)
    Sunday, May 16, 8:45 a.m.
    Intramural Research at NIH: Improving Functional Outcomes in COPD
    Nancy K. Leidy, PhD, Senior Vice President, Scientific Affairs, United BioSource Corporation

    Session Title: Meet the Professor
    Sunday, May 16, 12 p.m.
    Objective Measurement of Subjective Phenomena: Patient-Reported Outcome Measurement in Clinical Studies
    Nancy K. Leidy, PhD, Senior Vice President, Scientific Affairs, United BioSource Corporation


    Poster Presentations
    The CAT Can Detect Improvements in Overall COPD Health Status Associated with Recovery from Acute Exacerbations
    Jones P, Harding G, Wiklund I, Yu R, Leidy NK

    The CAT Can Detect COPD Health Status Gains Resulting from Rehabilitation Programmes
    Jones P, Harding G, Wiklund I, Berry P, Tabberer M, Yu R, Leidy NK

    Patient Willingness to Pay for Specific Attributes of Maintenance Medication for COPD
    Kleinman L, Kawata AK, Harding G, Ramachandran S

    Reliability and Validity of the Shortness of Breath with Daily Activity (SOBDA) Questionnaire: A New Outcome Measure for Evaluating Dyspnea in COPD
    Wilcox T, Chen WH, Howard KA, Cates CE, Wiklund I, Watkins ML, Brooks J, Tabberer M, Crim C

    Smoking, Smoking Cessation, and Smoking Relapse Patterns in the US: A Web-Based Survey of Current and Former Smokers
    Yeomans K, Marton JP, Merikle E, Ishak KJ, Proskorovsky I, Zou KH, Willke RJ, Payne KA

  • The Canadian Pain Society Annual Conference

    May 12 - May 15 2010
    Calgary, Alberta, Canada
    www.canadianpainsociety.ca/congres/calgary2010/index.htm

    Presentation
    Methodology of a Web-based Observational Study to Evaluate the Impact of Opioid Tolerability Issues on Chronic Pain Management
    Rod K, Kozak J, Payne K, Prinzo R

  • ABN (Association of British Neurologists) Annual Meeting 2010

    May 11 - May 14 2010
    Bournemouth, UK
    www.theabn.org/Home.aspx

    Poster Presentation
    Impact of Chronic versus Episodic Migraine on Disability, HRQOL and Healthcare Resource Utilisation in the UK
    Goadsby P, Lipton R, Varon S, Buse D, Kawata A, Wilcox T, Girod I, Blumenfeld A

  • ARVO 2010 Annual Meeting

    May 2 - May 6 2010
    Fort Lauderdale, FL, USA
    www.arvo.org/eweb/startpage.aspx?site=AM2010

    Poster Presentations
    Effect of Dexamethasone Intravitreal Implant on Patient-Reported Visual Functioning for the Treatment of Macular Edema Following Retinal Vein Occlusion
    Kowalski JW, Rentz A, Revicki D, Heier J, Belfort R, Haller J, Liu C-C, Whitcup SM

    Efficacy of Dexamethasone Intravitreal Implant for the Treatment of Uveitis Based on Patient-Reported Vision Function Outcome Measures
    Naik RK, Gelhorn H, Kowalski JW, Cui H, Revicki D, Lowder CY, Belfort Jr R, Foster S, Lightman S, Whitcup SM

    Normative Comparison of Generic and Vision-Targeted Health-Related Quality of Life (HRQL) Outcomes in Patients with Vision Loss Due to Macular Edema Following Retinal Vein Occlusion
    Rentz A, Kowalski JW, Revicki D, Loewenstein A, Blumenkranz M, Yoon Y, Whitcup SM

  • Digestive Disease Week 2010

    May 1 - May 5 2010
    New Orleans, LA, USA
    www.ddw.org/wmspage.cfm?parm1=679

    Poster Presentation
    Prevalence of Constipation and Fecal Incontinence in Men and Women with Overactive Bladder and Lower Urinary Tract Symptoms
    Cash BD, Coyne KS, Kopp ZS, Gelhorn H, Berriman S, Khullar V

  • Society of Cardiovascular Anesthesiologists 32 Annual Meeting & Workshops

    Apr 24 - Apr 28 2010
    New Orleans, LA, USA
    www.scahq.org/

    Poster Presentation
    The Impact of Perioperative Blood Pressure Control on Hospitalization Costs in Patients Undergoing Cardiac Surgery: Results from ECLIPSE
    Multz AS, Dyke CM, Hu M, Wang Y, Williams GC, Ferguson J, Getsios D, Ishak J, Alvarez P, Stolar M, Aronson S

  • 19th Annual Partnerships in Clinical Trials

    Apr 12 - Apr 14 2010
    Orlando, FL, USA
    www.iirusa.com/cropartners/welcome-to-CROs.xml

    Panel Discussion
    RiskMaps, Registries and REMS: Next Generation Post Marketing Research (PMR) and Obligations to Meet Regulatory Standards and Enhance Patient Safety
    Moderator: John Balian, MD, Senior Vice President, Global Pharmacovigilance and Epidemiology, Bristol-Myers Squibb
    Panelists: Maria Harrison, Vice President, Late Phase Services, PRA International; Thomas More, Technical Manager, NYCLIX; Amrit Ray, MD, MBA, FCMI, Chief Safety Officer, Head, Global Medical Safety, Johnson & Johnson Pharmaceuticals Group;  Annette Stemhagen, DrPH, FISPE, Senior Vice President, Epidemiology, Registries and Risk Management, United BioSource Corporation; Philippe Van der Auwere, MD, PhD, Global Head of Safety Risk Management (PDS) & EU-QPPV, Pharma Development, F. Hoffmann-La Roche Ltd.

  • 2010 American Academy of Neurology (AAN) Annual Meeting

    Apr 10 - Apr 17 2010
    Toronto, ON, Canada
    www.aan.com/go/am10
    Poster Presentations
    Determinants of Migraine-Related Disability
    Lipton RB, Blumenfeld A, Ishak KJ, Varon SF, Kawata AK, Manack A, Buse DC, Goadsby PJ

    Effectiveness of Memantine in Patient with Moderate to Severe Alzheimer's Disease as Measured by Caregiver Perceived Burden Questionnaire (CPBQ)
    Wilcox T, Chen W-H, OQuinn S, Setyawan J, Saxton J, Erder MH

    Relationship Between Headache Frequency and Migraine-Related Disability in the International Burden of Migraine Study (IBMS)
    Wilcox TK, Blumenfeld A, Varon SF, Payne KA, Manack A, Buse DC, Goadsby PJ, Lipton RB

  • DIA Evidence-Based Medicine and Health Technology Assessment: Moving from Separate Appraisals to Synergistic Communications

    Mar 23 - Mar 24 2010
    Washington, DC, USA
    www.diahome.org


    Tuesday, Mar. 23, 3:30 - 5:00 p.m.

    SESSION 2 - Evidence Hierarchies and Methodological Best Practices
    Speaker
    Designing Studies for Better Evidence
    Bryan Luce, PhD, Senior Vice President, Science Policy, United BioSource Corporation

    Tuesday, Mar. 23, 5:30 - 6:30 p.m.

    Poster Presentation
    Do Comparative Effectiveness Reviews Make an Impact? A Case Study of AHRQ Effective Health Care Program Reports
    Singer Cohen R, Hunter C

  • Pharmaceutical Education & Research Institute (PERI) - Asthma and COPD: Clinical Drug Development Course

    Mar 22 - Mar 23 2010
    Arlington, VA, USA
    www.peri.org/course_details.cfm?course=1972

    Course Presentation
    Patient-Reported Outcomes for Asthma and COPD
    Instructor: Nancy Kline Leidy, PhD, Senior Vice President, Scientific Affairs, United BioSource Corporation

  • European Pharmaceutical Reimbursement & Market Access Conference

    Mar 8 - Mar 9 2010
    London, UK
    www.q1productions.com/eventPages/event_LSCONF-2016.php

    Session Presentation
    Pricing, Reimbursement and Market Access Strategies for Orphan Medicines
    Adam Barak, Head, International Pricing and Reimbursement, United BioSource Corporation

  • The International Society for CNS Clinical Trials and Methodology (ISCTM) 2010 Mental Health Research-To-Policy Forum

    Feb 23 - Feb 23 2010
    Washington, DC, USA
    www.isctm.org/


    8:30 - 11:30 a.m.
    Session: The Role of CER in Future Mental Health Policy Decision Making

    Presenter
    CER 2010: Critical Review of the Current Science and the Politics of CER
    Bryan R. Luce, PhD, MBA, Senior Vice President, Science Policy, United BioSource Corporation

  • International Society for the Study of Women’s Sexual Health 2010 Annual Meeting

    Feb 18 - Feb 21 2010
    St. Petersburg, FL, USA
    www.isswsh.org/

    Presentation
    The Impact of Hypoactive Sexual Desire Disorder (HSDD) on Women and Their Relationships: Qualitative Data from Patient Focus Groups
    Revicki D, Fisher W, Rosen R, Kuppermann M, Margolis MK, Hanes V

  • Preventive Medicine 2010

    Feb 17 - Feb 20 2010
    Washington, DC, USA
    www.preventivemedicine2010.org/

    Poster Presentation
    Psychosocial Effects of Frequent Heartburn: A Nationally Representative Survey of Frequent Heartburn Sufferers in America
    Stull DE, van Hanswijck de Jonge P, Winnette R, Fennerty MB, Farber M, Ferguson D, Fourcroy J, Sandor DW

  • Joint DIA / IFAPP Pharmaceutical Policy Forum

    Feb 4 - Feb 5 2010
    London, UK
    www.diahome.org

    Presentation
    Economic and Reimbursement Drivers for Pharma / Healthcare Collaboration
    Robert M.A. Thwaites, MA, Senior Executive Director - Europe, United BioSource Corporation

  • Adaptive Designs in Clinical Drug Development

    Feb 3 - Feb 4 2010
    London, UK
    www.smi-online.co.uk/events/overview.asp?is=4&ref=3182

    Presentation
    Implementing Adaptive Design: A Technology Perspective
    Scott Hamilton, Senior Director, Biometrics and Randomisation Technologies, United BioSource Corporation

  • COPD Biomarkers Qualification Workshop

    Jan 27 - Jan 28 2010
    Bethesda, MD, USA
    www.copdfoundation.org


    Presentation
    The Exacerbations of Chronic Pulmonary Disease Tool - Patient-Reported Outcomes (EXACT-PRO)
    Nancy K. Leidy, PhD, Senior Vice President, Scientific Affairs, United BioSource Corporation